Author

Eva A. Schulte

Observed names: EA Schulte, Eva Schulte

Observed institutions: Philipps University of Marburg, University of Dundee, University of Münster, Ninewells Hospital

OpenAlex ID: A5110063183

Protein Kinase CK2, Cystic Fibrosis Transmembrane Conductance Regulator, and the ΔF508 Mutation

2007 · Kate J. Treharne, Russell M. Crawford, et al. · Journal of Biological Chemistry · 15

Effects of clozapine and its metabolites on the 5-HT2 receptor system in cortical and hippocampal cells in vitro

2003 · Philip Heiser, Eva Schulte, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 10

Pharmacokinetics of clozapine and its metabolites in hippocampal HT22 cells

2003 · Philip Heiser, M Schüler-Springorum, et al. · European Journal of Pharmacology · 6

Diadenosine Polyphosphates and Atrial Natriuretic Peptide are Antiproliferative in Rat Mesangial Cells

2000 · Eva A. Schulte, Hilmi Saleh, et al. · Cellular Physiology and Biochemistry · 6

Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the ΔF508 mutation. F508 deletion disrupts a kinase-binding site (Journal of Biological Chemistry (2007) 282, (10804-10813))

2008 · KJ Treharne, R. R. Crawford, et al. · 3

Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the ΔF508 mutation. F508 deletion disrupts a kinase-binding site. VOLUME 282 (2007) PAGES 10804-10813

2008 · Kate J. Treharne, Russell M. Crawford, et al. · Journal of Biological Chemistry · 2

Therapeutische Krebsimpfung - wann sind wir soweit?

2012 · Eva A. Schulte

Works count: 7

Citation count: 42

H-index: 4

I10-index: 2